MDXG News and Press, MiMedx Group Inc From 09/17/20

Research in Plantar Fasciitis Advances Understanding of Amniotic Tissue as Potential Treatment for Chronic Musculoskeletal Pain and Function Disorders MARIETTA, Ga., Sept. 17, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company&#x...

Ampio Pharmaceuticals Inc. ( AMPE ) has had a long road to FDA approval for its osteoarthritis drug called Ampion. It's been 9 years and 5 clinical trials in the making, and they are in their final push for approval. There is clear evidence suggestive of approval for Ampion in osteoarthritis o...

New Allograft Expands to Twice its Size and Provides a Protective Structure to Support the Wound Healing Cascade MARIETTA, Ga., Sept. 14, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced ...

MARIETTA, Ga., Aug. 24, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today provided additional information about its upcoming vi...

MiMedx Group, Inc. (MDXG) Q2 2020 Earnings Conference Call August 11, 2020 08:30 AM ET Company Participants Hilary Dixon - VP of IR and Corporate Communications Tim Wright - CEO Pete Carlson - CFO Conference Call Participants Presentation Operator Good morning and w...

MARIETTA, Ga., Aug. 10, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced the addition of Robert B. Stein, M.D., Ph.D....

MiMedx Group ( OTCPK:MDXG ) : Q2 GAAP EPS of -$0.08. Revenue of $53.65M (-20.4% Y/Y) Press Release More news on: MiMedx Group, Inc., Earnings news and commentary, Healthcare stocks news,

Second Quarter Net Sales of $53.6 million Results Reflects Tight Cost Containment Efforts Company to Host Shareholder Update Call on August 11, 2020 MARIETTA, Ga., Aug. 04, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or the “Comp...

MARIETTA, Ga., Aug. 03, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that it has filed a definitive proxy stateme...

MARIETTA, Ga., July 28, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced the addition of Rohit Kashyap, Ph.D., as Exe...